<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Few Pediatric Trials Had Safety Monitoring: Study</title>
	<atom:link href="http://www.pharmalot.com/2008/03/few-pediatric-trials-had-safety-monitoring-study/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2008/03/few-pediatric-trials-had-safety-monitoring-study/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Fri, 10 Feb 2012 21:10:08 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Gary Pitt</title>
		<link>http://www.pharmalot.com/2008/03/few-pediatric-trials-had-safety-monitoring-study/#comment-218499</link>
		<dc:creator>Gary Pitt</dc:creator>
		<pubDate>Thu, 20 Mar 2008 19:16:29 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/03/few-pediatric-trials-had-safety-monitoring-study/#comment-218499</guid>
		<description>Ed-  I'm impressed with your follow-up.  Thanks!</description>
		<content:encoded><![CDATA[<p>Ed-  I&#8217;m impressed with your follow-up.  Thanks!</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Ed Silverman</title>
		<link>http://www.pharmalot.com/2008/03/few-pediatric-trials-had-safety-monitoring-study/#comment-218043</link>
		<dc:creator>Ed Silverman</dc:creator>
		<pubDate>Thu, 20 Mar 2008 16:06:09 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/03/few-pediatric-trials-had-safety-monitoring-study/#comment-218043</guid>
		<description>To Gary Pitt, Outside the Box and Jack2,

The lead author has replied to your questions. Please scroll to the bottom of the post to read her answers.

Regards
ed</description>
		<content:encoded><![CDATA[<p>To Gary Pitt, Outside the Box and Jack2,</p>
<p>The lead author has replied to your questions. Please scroll to the bottom of the post to read her answers.</p>
<p>Regards<br />
ed</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Ed Silverman</title>
		<link>http://www.pharmalot.com/2008/03/few-pediatric-trials-had-safety-monitoring-study/#comment-217854</link>
		<dc:creator>Ed Silverman</dc:creator>
		<pubDate>Thu, 20 Mar 2008 13:00:37 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/03/few-pediatric-trials-had-safety-monitoring-study/#comment-217854</guid>
		<description>Jack2, Gary Pitt and Outside,

I've just included links to the study and some tables. I'm still waiting for the lead author to reply to my note. 

Regards
ed</description>
		<content:encoded><![CDATA[<p>Jack2, Gary Pitt and Outside,</p>
<p>I&#8217;ve just included links to the study and some tables. I&#8217;m still waiting for the lead author to reply to my note. </p>
<p>Regards<br />
ed</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Lisa Van S</title>
		<link>http://www.pharmalot.com/2008/03/few-pediatric-trials-had-safety-monitoring-study/#comment-216880</link>
		<dc:creator>Lisa Van S</dc:creator>
		<pubDate>Wed, 19 Mar 2008 20:47:24 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/03/few-pediatric-trials-had-safety-monitoring-study/#comment-216880</guid>
		<description>Jack2

Unfortunately, Im not making anything up, personal experience! May I direct you to the Starledger's online edition. On the left hand side you will see links to NJ's UMDNJ Scandal. You can also google Dr. Marie Carmen Palazzo!</description>
		<content:encoded><![CDATA[<p>Jack2</p>
<p>Unfortunately, Im not making anything up, personal experience! May I direct you to the Starledger&#8217;s online edition. On the left hand side you will see links to NJ&#8217;s UMDNJ Scandal. You can also google Dr. Marie Carmen Palazzo!</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Ed Silverman</title>
		<link>http://www.pharmalot.com/2008/03/few-pediatric-trials-had-safety-monitoring-study/#comment-216831</link>
		<dc:creator>Ed Silverman</dc:creator>
		<pubDate>Wed, 19 Mar 2008 19:43:32 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/03/few-pediatric-trials-had-safety-monitoring-study/#comment-216831</guid>
		<description>Dear Jack2, Gary and Outside,

I have asked the lead author to answer your questions. Hopefully, she will reply, and either write to me directly, in which case I will post her answers and alert you to their existence, or she post them here herself.

You've asked good questions and, since I've not spoken with her and also don't have access to the complete study, I'm curious to learn what she has to say.

Thanks for writing in,
Cheers
ed</description>
		<content:encoded><![CDATA[<p>Dear Jack2, Gary and Outside,</p>
<p>I have asked the lead author to answer your questions. Hopefully, she will reply, and either write to me directly, in which case I will post her answers and alert you to their existence, or she post them here herself.</p>
<p>You&#8217;ve asked good questions and, since I&#8217;ve not spoken with her and also don&#8217;t have access to the complete study, I&#8217;m curious to learn what she has to say.</p>
<p>Thanks for writing in,<br />
Cheers<br />
ed</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Outside the Box</title>
		<link>http://www.pharmalot.com/2008/03/few-pediatric-trials-had-safety-monitoring-study/#comment-216814</link>
		<dc:creator>Outside the Box</dc:creator>
		<pubDate>Wed, 19 Mar 2008 19:20:41 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/03/few-pediatric-trials-had-safety-monitoring-study/#comment-216814</guid>
		<description>What proportion of the trials for these drugs in adults used an independent safety monitoring committee? Is there clear evidence to show that the absence of a safety monitoring committee resulted in a higher rate of safety related events in these trials?

In other words, to what extent is this a real concern that trials in children were less well monitored, and as a result less safe, than was the case for the same products when tested on adults?</description>
		<content:encoded><![CDATA[<p>What proportion of the trials for these drugs in adults used an independent safety monitoring committee? Is there clear evidence to show that the absence of a safety monitoring committee resulted in a higher rate of safety related events in these trials?</p>
<p>In other words, to what extent is this a real concern that trials in children were less well monitored, and as a result less safe, than was the case for the same products when tested on adults?</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Gary Pitt</title>
		<link>http://www.pharmalot.com/2008/03/few-pediatric-trials-had-safety-monitoring-study/#comment-216805</link>
		<dc:creator>Gary Pitt</dc:creator>
		<pubDate>Wed, 19 Mar 2008 19:15:38 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/03/few-pediatric-trials-had-safety-monitoring-study/#comment-216805</guid>
		<description>Good point Jack2 - Ed, is this something you might be able to share?</description>
		<content:encoded><![CDATA[<p>Good point Jack2 - Ed, is this something you might be able to share?</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Jack2</title>
		<link>http://www.pharmalot.com/2008/03/few-pediatric-trials-had-safety-monitoring-study/#comment-216761</link>
		<dc:creator>Jack2</dc:creator>
		<pubDate>Wed, 19 Mar 2008 18:04:54 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/03/few-pediatric-trials-had-safety-monitoring-study/#comment-216761</guid>
		<description>So now you're just making stuff up Lisa?

Ed: Any indication in the article about the %'s by trial-type for industry run trials (A), industry-sponsored investigator-initiated trials (B), and government-sponsored trials (C)?  I can't read the whole article.  If I may make stuff up: we would find the highest percents in group A, and the lowest in group C.

What's your take on this ol'cranky?</description>
		<content:encoded><![CDATA[<p>So now you&#8217;re just making stuff up Lisa?</p>
<p>Ed: Any indication in the article about the %&#8217;s by trial-type for industry run trials (A), industry-sponsored investigator-initiated trials (B), and government-sponsored trials (C)?  I can&#8217;t read the whole article.  If I may make stuff up: we would find the highest percents in group A, and the lowest in group C.</p>
<p>What&#8217;s your take on this ol&#8217;cranky?</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Dan</title>
		<link>http://www.pharmalot.com/2008/03/few-pediatric-trials-had-safety-monitoring-study/#comment-216750</link>
		<dc:creator>Dan</dc:creator>
		<pubDate>Wed, 19 Mar 2008 17:50:05 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/03/few-pediatric-trials-had-safety-monitoring-study/#comment-216750</guid>
		<description>Many peds trials are performed to extend the patent of already marketed drugs primarily to adults.</description>
		<content:encoded><![CDATA[<p>Many peds trials are performed to extend the patent of already marketed drugs primarily to adults.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Lisa Van S</title>
		<link>http://www.pharmalot.com/2008/03/few-pediatric-trials-had-safety-monitoring-study/#comment-216746</link>
		<dc:creator>Lisa Van S</dc:creator>
		<pubDate>Wed, 19 Mar 2008 17:40:05 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/03/few-pediatric-trials-had-safety-monitoring-study/#comment-216746</guid>
		<description>This is pretty frightening!!!. Im sure the clinical trials of antipsychotics in children went unmonitored.</description>
		<content:encoded><![CDATA[<p>This is pretty frightening!!!. Im sure the clinical trials of antipsychotics in children went unmonitored.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.159 seconds -->

